WallStreetZenWallStreetZen

NASDAQ: RAPT
Rapt Therapeutics Inc Stock Ownership - Who owns Rapt Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Rapt Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Dirk G. BrockstedtCHIEF SCIENTIFIC OFFICER2024-01-05898$22.78
$20.46kSell
Dirk G. BrockstedtChief Scientific Officer2023-12-298,000$6.18
$49.44kBuy
William 1. HoChief Medical Officer2023-12-212,500$21.68
$54.20kSell
William 1. HoChief Medical Officer2023-11-281,500$13.72
$20.58kSell
William 1. HoChief Medical Officer2023-10-032,500$15.77
$39.43kSell
William 1. HoChief Medical Officer2023-08-182,500$18.92
$47.30kSell
William 1. HoChief Medical Officer2023-07-28460$12.00
$5.52kBuy
William 1. HoChief Medical Officer2023-06-23920$12.00
$11.04kBuy

1 of 1

RAPT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RAPT insiders and whales buy or sell their stock.

RAPT Shareholders

What type of owners hold Rapt Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
David V. Goeddel19.48%6,777,151$53.27MInsider
Kleiner Perkins Caufield Byers Xv LLC15.79%5,494,126$43.18MInsider
Fmr LLC11.04%3,843,387$30.21MInstitution
Price T Rowe Associates Inc9.81%3,413,552$26.83MInstitution
Topspin Fund LP9.01%3,134,614$24.64MInsider
Column Group LLC7.70%2,680,621$21.07MInstitution
Blackrock Inc7.05%2,453,049$19.28MInstitution
Perceptive Advisors LLC6.15%2,139,950$16.82MInstitution
Vanguard Group Inc5.91%2,056,221$16.16MInstitution
Deep Track Capital LP5.16%1,793,966$14.10MInstitution

1 of 3

RAPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RAPT66.33%33.67%Net Selling
IMMP0.17%0.00%
INZY54.64%45.36%Net BuyingNet Selling
GLUE24.82%75.18%
VNDA56.23%43.77%Net SellingNet Selling
View Top Biotech Stocks

Rapt Therapeutics Stock Ownership FAQ

Who owns Rapt Therapeutics?

Rapt Therapeutics (NASDAQ: RAPT) is owned by 100.49% institutional shareholders, 51.01% Rapt Therapeutics insiders, and 0.00% retail investors. David V. Goeddel is the largest individual Rapt Therapeutics shareholder, owning 6.78M shares representing 19.48% of the company. David V. Goeddel's Rapt Therapeutics shares are currently valued at $53.27M.

If you're new to stock investing, here's how to buy Rapt Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.